FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1916572050> ?p ?o ?g. }

• W1916572050 endingPage "405" @default.
• W1916572050 startingPage "394" @default.
• W1916572050 abstract "The prevalence of allergic skin disorders has increased rapidly, and development of therapeutic agents to alleviate the symptoms are still needed. In this study, we orally or topically administered the Janus kinase (JAK) inhibitors, tofacitinib and oclacitinib, in a mouse model of dermatitis, and compared the efficacy to reduce the itch and inflammatory response. In vitro effects of JAK inhibitors on bone marrow-derived dendritic cells (BMDCs) were analyzed. For the allergic dermatitis model, female BALB/c mice were sensitized and challenged with toluene-2,4-diisocyanate (TDI). Each JAK inhibitor was orally or topically applied 30 minutes before and 4 hours after TDI challenge. After scratching bouts and ear thickness were measured, cytokines were determined in challenged skin and the cells of the draining lymph node were analyzed by means of flow cytometry. In vitro, both JAK inhibitors significantly inhibited cytokine production, migration, and maturation of BMDCs. Mice treated orally with JAK inhibitors showed a significant decrease in scratching behavior; however, ear thickness was not significantly reduced. In contrast, both scratching behavior and ear thickness in the topical treatment group were significantly reduced compared with the vehicle treatment group. However, cytokine production was differentially regulated by the JAK inhibitors, with some cytokines being significantly decreased and some being significantly increased. In conclusion, oral treatment with JAK inhibitors reduced itch behavior dramatically but had only little effect on the inflammatory response, whereas topical treatment improved both itch and inflammatory response. Although the JAK-inhibitory profile differs between both JAK inhibitors in vitro as well as in vivo, the effects have been comparable." @default.
• W1916572050 created "2016-06-24" @default.
• W1916572050 creator A5001420935 @default.
• W1916572050 creator A5033924492 @default.
• W1916572050 creator A5049295699 @default.
• W1916572050 creator A5084474090 @default.
• W1916572050 date "2015-07-09" @default.
• W1916572050 modified "2023-10-17" @default.
• W1916572050 title "Topically Administered Janus-Kinase Inhibitors Tofacitinib and Oclacitinib Display Impressive Antipruritic and Anti-Inflammatory Responses in a Model of Allergic Dermatitis" @default.
• W1916572050 cites W1605253652 @default.
• W1916572050 cites W1671779243 @default.
• W1916572050 cites W1965037455 @default.
• W1916572050 cites W1966518661 @default.
• W1916572050 cites W1973105799 @default.
• W1916572050 cites W1974080412 @default.
• W1916572050 cites W1980927217 @default.
• W1916572050 cites W1983163536 @default.
• W1916572050 cites W1984317973 @default.
• W1916572050 cites W1986178253 @default.
• W1916572050 cites W1986729547 @default.
• W1916572050 cites W1991688187 @default.
• W1916572050 cites W2000590032 @default.
• W1916572050 cites W2005634676 @default.
• W1916572050 cites W2010923089 @default.
• W1916572050 cites W2019402966 @default.
• W1916572050 cites W2023949683 @default.
• W1916572050 cites W2028648418 @default.
• W1916572050 cites W2033718502 @default.
• W1916572050 cites W2035817785 @default.
• W1916572050 cites W2037845415 @default.
• W1916572050 cites W2046710165 @default.
• W1916572050 cites W2048964610 @default.
• W1916572050 cites W2051674260 @default.
• W1916572050 cites W2054717635 @default.
• W1916572050 cites W2077215378 @default.
• W1916572050 cites W2078678444 @default.
• W1916572050 cites W2083245833 @default.
• W1916572050 cites W2092235636 @default.
• W1916572050 cites W2107010278 @default.
• W1916572050 cites W2124014177 @default.
• W1916572050 cites W2135694095 @default.
• W1916572050 cites W2139672588 @default.
• W1916572050 cites W2139696655 @default.
• W1916572050 cites W2147889176 @default.
• W1916572050 cites W2149189075 @default.
• W1916572050 cites W2156486811 @default.
• W1916572050 cites W2158259619 @default.
• W1916572050 cites W2162548536 @default.
• W1916572050 cites W2163184895 @default.
• W1916572050 cites W2163462022 @default.
• W1916572050 cites W2316122533 @default.
• W1916572050 cites W4211044813 @default.
• W1916572050 doi "https://doi.org/10.1124/jpet.115.223784" @default.
• W1916572050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26159873" @default.
• W1916572050 hasPublicationYear "2015" @default.
• W1916572050 type Work @default.
• W1916572050 sameAs 1916572050 @default.
• W1916572050 citedByCount "76" @default.
• W1916572050 countsByYear W19165720502016 @default.
• W1916572050 countsByYear W19165720502017 @default.
• W1916572050 countsByYear W19165720502018 @default.
• W1916572050 countsByYear W19165720502019 @default.
• W1916572050 countsByYear W19165720502020 @default.
• W1916572050 countsByYear W19165720502021 @default.
• W1916572050 countsByYear W19165720502022 @default.
• W1916572050 countsByYear W19165720502023 @default.
• W1916572050 crossrefType "journal-article" @default.
• W1916572050 hasAuthorship W1916572050A5001420935 @default.
• W1916572050 hasAuthorship W1916572050A5033924492 @default.
• W1916572050 hasAuthorship W1916572050A5049295699 @default.
• W1916572050 hasAuthorship W1916572050A5084474090 @default.
• W1916572050 hasBestOaLocation W19165720501 @default.
• W1916572050 hasConcept C112392421 @default.
• W1916572050 hasConcept C203014093 @default.
• W1916572050 hasConcept C207480886 @default.
• W1916572050 hasConcept C2776056826 @default.
• W1916572050 hasConcept C2776233030 @default.
• W1916572050 hasConcept C2777575956 @default.
• W1916572050 hasConcept C2778329239 @default.
• W1916572050 hasConcept C2778690821 @default.
• W1916572050 hasConcept C2778886723 @default.
• W1916572050 hasConcept C2780938799 @default.
• W1916572050 hasConcept C71924100 @default.
• W1916572050 hasConcept C98274493 @default.
• W1916572050 hasConceptScore W1916572050C112392421 @default.
• W1916572050 hasConceptScore W1916572050C203014093 @default.
• W1916572050 hasConceptScore W1916572050C207480886 @default.
• W1916572050 hasConceptScore W1916572050C2776056826 @default.
• W1916572050 hasConceptScore W1916572050C2776233030 @default.
• W1916572050 hasConceptScore W1916572050C2777575956 @default.
• W1916572050 hasConceptScore W1916572050C2778329239 @default.
• W1916572050 hasConceptScore W1916572050C2778690821 @default.
• W1916572050 hasConceptScore W1916572050C2778886723 @default.
• W1916572050 hasConceptScore W1916572050C2780938799 @default.
• W1916572050 hasConceptScore W1916572050C71924100 @default.
• W1916572050 hasConceptScore W1916572050C98274493 @default.
• W1916572050 hasIssue "3" @default.
• W1916572050 hasLocation W19165720501 @default.

• next